Nebraska Methodist Hospital; Cancer Center

Omaha, Nebraska 68114

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Neoplasms, Hormone Refractory Prostate Cancer, Prostate Cancer, Urothelial Carcinoma

Studies at this site

• A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy — Stopped early
• Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer — Stopped early
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed